Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Non-Current Deferred Tax Liability (2019)

Historic Non-Current Deferred Tax Liability for Marker Therapeutics (MRKR) over the last 1 years, with Q4 2019 value amounting to $106000.0.

  • Marker Therapeutics' Non-Current Deferred Tax Liability changed N/A to $106000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $106000.0, marking a year-over-year change of. This contributed to the annual value of $106000.0 for FY2019, which is N/A changed from last year.
  • Marker Therapeutics' Non-Current Deferred Tax Liability amounted to $106000.0 in Q4 2019.
  • Marker Therapeutics' 5-year Non-Current Deferred Tax Liability high stood at $106000.0 for Q4 2019, and its period low was $106000.0 during Q4 2019.